Concurrent intestinal plasmablastic lymphoma and diffuse large B-cell lymphoma with a clonal relationship: a case report and literature review

被引:0
作者
Imuta, Nao [1 ,2 ]
Miyai, Kosuke [2 ,3 ]
Tsuchiya, Motohiro [2 ,3 ]
Saito, Mariko [3 ]
Sone, Takehiro [4 ]
Kobayashi, Shinichi [4 ]
Ogata, Sho [2 ,3 ]
Kimura, Fumihiko [4 ]
Matsukuma, Susumu [2 ,3 ]
机构
[1] Natl Def Med Coll, Tokorozawa, Japan
[2] Natl Def Med Coll, Dept Pathol & Lab Med, Tokorozawa, Japan
[3] Natl Def Med Coll Hosp, Dept Lab Med, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan
[4] Natl Def Med Coll, Dept Hematol, Tokorozawa, Japan
关键词
Plasmablastic lymphoma; Diffuse large B-cell lymphoma; Concurrent lymphoma; Sequencing analysis; Clonal relationship; PATIENT; FLUDARABINE;
D O I
10.4132/jptm.2024.05.14
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Herein, we report a case of plasmablastic lymphoma (PBL) and diffuse large B-cell lymphoma (DLBCL) that occurred concurrently in the large intestine. An 84-year-old female presented with a palpable rectal tumor and ileocecal tumor observed on imaging analyses. Endoscopic biopsy of both lesions revealed lymphomatous round cells. Hartmann's operation and ileocecal resection were performed for regional control. The ileocecal lesion consisted of a proliferation of CD20/CD79a-positive lymphoid cells, indicative of DLBCL. In contrast, the rectal tumor showed proliferation of atypical cells with pleomorphic nuclei and abundant amphophilic cytoplasm, with immunohistochemical findings of CD38/CD79a/MUM1/MYC (+) and CD20/CD3/CD138/PAX5 (-). Tumor cells were positive for Epstein-Barr virus- encoded RNA based on in situ hybridization and MYC rearrangement in fluorescence in situ hybridization analysis. These findings indicated the rectal tumor was most likely a PBL. Sequencing analysis for immunoglobulin heavy variable genes indicated a common B-cell origin of the two sets of lymphoma cells. This case report and literature review provide new insights into PBL tumorigenesis.
引用
收藏
页码:191 / 197
页数:7
相关论文
共 20 条
[1]   Plasmablastic lymphoma: An update [J].
Bailly, Jenique ;
Jenkins, Nicholas ;
Chetty, Dharshnee ;
Mohamed, Zainab ;
Verburgh, Estelle R. ;
Opie, Jessica J. .
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2022, 44 :54-63
[2]  
Campo E., 2017, WHO CLASSIFICATION T, VRevised 4th ed, P321
[3]   Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma [J].
Castillo, Jorge J. ;
Guerrero-Garcia, Thomas ;
Baldini, Francesco ;
Tchernonog, Emmanuelle ;
Cartron, Guillaume ;
Ninkovic, Slavisa ;
Cwynarski, Kate ;
Dierickx, Daan ;
Tousseyn, Thomas ;
Lansigan, Frederick ;
Linnik, Yevgeny ;
Mogollon, Renzo ;
Navarro, Jose-Tomas ;
Olszewski, Adam J. ;
Reagan, John L. ;
Fedele, Pasquale ;
Gilbertson, Michael ;
Grigoriadis, George ;
Bibas, Michele .
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (04) :679-682
[4]   Prognostic Factors in Chemotherapy-Treated Patients with HIV-Associated Plasmablastic Lymphoma [J].
Castillo, Jorge J. ;
Winer, Eric S. ;
Stachurski, Dariusz ;
Perez, Kimberly ;
Jabbour, Melhem ;
Milani, Cannon ;
Colvin, Gerald ;
Butera, James N. .
ONCOLOGIST, 2010, 15 (03) :293-299
[5]   Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus [J].
Foo, Wen-Chi ;
Huang, Qin ;
Sebastian, Siby ;
Hutchinson, Charles B. ;
Burchette, Jim ;
Wang, Endi .
HUMAN PATHOLOGY, 2010, 41 (12) :1802-1808
[6]   Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma [J].
Garcia-Reyero, Julia ;
Martinez Magunacelaya, Nerea ;
Gonzalez de Villambrosia, Sonia ;
Loghavi, Sanam ;
Gomez Mediavilla, Angela ;
Tonda, Raul ;
Beltran, Sergi ;
Gut, Marta ;
Perena Gonzalez, Ainara ;
D'Amore, Emmanuel ;
Visco, Carlo ;
Khoury, Joseph D. ;
Montes-Moreno, Santiago .
HAEMATOLOGICA, 2021, 106 (04) :1120-1128
[7]   Bortezomib in plasmablastic lymphoma: A glimpse of hope for a hard-to-treat disease [J].
Guerrero-Garcia, Thomas A. ;
Mogollon, Renzo J. ;
Castillo, Jorge J. .
LEUKEMIA RESEARCH, 2017, 62 :12-16
[8]   Clonally Related Plasmablastic Lymphoma Simultaneously Occurring with Diffuse Large B-Cell Lymphoma [J].
Hashimoto, Norisato ;
Ueda, Tomoki ;
Hiraiwa, Shinichiro ;
Tajiri, Takuma ;
Nakamura, Naoya ;
Yokoyama, Kenji .
CASE REPORTS IN HEMATOLOGY, 2020, 2020
[9]  
Hatzimichael E, 2017, CASE REP HEMATOL, V2017, DOI 10.1155/2017/2861596
[10]   Brentuximab Vedotin Demonstrates Activity in a Patient With Plasmablastic Lymphoma Arising From a Background of Chronic Lymphocytic Leukemia [J].
Holderness, Britt M. ;
Malhotra, Saurabh ;
Levy, Norman B. ;
Danilov, Alexey V. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (12) :E197-E199